|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/74 | (2015.01) |
| A61K 35/74 | (2013.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 13/00 | (2006.01) | ||
| A61P 13/12 | (2006.01) |
| (11) | Number of the document | 3468572 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17730457.3 |
| Date of filing the European patent application | 2017-06-13 | |
| (97) | Date of publication of the European application | 2019-04-17 |
| (45) | Date of publication and mention of the grant of the patent | 2022-03-02 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2017/064422 |
| Date | 2017-06-13 |
| (87) | Number | WO 2017/216165 |
| Date | 2017-12-21 |
| (30) | Number | Date | Country code |
| 1650828 | 2016-06-13 | SE |
| (72) |
LINDNER, Elisabeth , SE
ÅKERMAN, Maria , SE
SJÖGREN, Anna , SE
MCCALLION, Orla , SE
|
| (73) |
OxThera Intellectual Property AB ,
Sturegatan 56, 114 36 Stockholm,
SE
|
| (54) | COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF OXALATE-RELATED DISORDERS |
| COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF OXALATE-RELATED DISORDERS |